Advertisement
 
News
Advertisement

Horizon Pharma Gets Nod for Arthritis Drug

Fri, 12/21/2012 - 10:19am

U.K. regulators will grant marketing approval to Horizon Pharma's arthritis combination pill, pending review of a few final documents, the company announced.

Duexis is used to treat osteoarthritis, rheumatoid arthritis and ankylosing spondylitis, an inflammatory disease of the spinal bones. The pill combines a prescription-strength dose of ibuprofen with a dose of famotidine, which is intended to prevent stomach ulcers associated with ibuprofen.

Duexis was previously approved in the U.S.

Date: December 21, 2012
Source: Associated Press

Advertisement

Share This Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading